Lucidplus™ Beta-hydroxybutyrate Assay Preffered by Hospital Laboratories
Proficiency Testing Programs Indicate Increase in Participants of Lucidplus™ Beta-Hydroxybutyrate Assay SAN ANTONIO, Texas, June 10, 2021 - Vidan [...]
Next Generation Beta-hydroxybutyrate Reagent For Beckman Coulter AU® Clinical Chemistry Systems
Vidan Diagnostics Extends Reagent Stability for β-Hydroxybutyrate 21FS Assay on Beckman AU® Clinical Chemistry Systems SAN ANTONIO, Texas, April 28, [...]
Availability of Beta-hydroxybutyrate on Roche cobas® Clinical Chemistry Systems
Reagent Application for β-Hydroxybutyrate 21FS Assay Now Available for Roche cobas® Clinical Chemistry Systems SAN ANTONIO, Texas, October 16, [...]
Availability of of Beta-hydroxybutyrate on Siemens Atellica®
Vidan Diagnostics Launches Reagent Application for its β-Hydroxybutyrate 21FS Assay on the Siemens Atellica® Clinical Chemistry System. SAN ANTONIO, Texas, [...]
Launch of QCnow™ Peer Review Program
Launch of QCnow™ Peer Review Program QCnow™ Enables Vidan Diagnostics Customers to Access On-demand Interlaboratory Quality Control Reports. SAN ANTONIO, [...]
Availability of Beta-hydroxybutyrate on Abbott Alinity™
Reagent Application for Vidan Diagnostics’ β-Hydroxybutyrate 21FS Assay is now available for Abbott Alnity™ Clinical Chemistry System. SAN ANTONIO, Texas, [...]